Osika W

Center for Social Sustainability, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.

19 papers · 1 preprint · ORCID

ArticlePsychedelics

Politically Salient Events May Modulate Effects of Naturalistic Psychedelic Use on Support for Partisan Violence.

Simonsson O, Hendricks PS, Osika W +1

Europe PMC2026
PreprintLSD

Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review

Sun S, Hanson C, Hendricks PS +9

Europe PMC2026
ArticlePsilocybin

Associations between psychedelic use and migraine history in Swedish twins.

Simonsson O, Sun S, Wesseldijk LW +3

Europe PMC2026
ArticlePsilocybin

Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.

Olofsson M, Osika W, Goldberg SB +6

Europe PMC2026
ArticlePsychedelics

Naturalistic psychedelic use and changes in depressive symptoms.

Simonsson O, Hendricks PS, Swords CM +2

Europe PMC2025
ArticlePsychedelics

Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms.

Simonsson O, Goldberg SB, Osika W +5

Europe PMC2025
ArticlePsychedelics

Associations between psychedelic-related and meditation-related variables: A longitudinal study.

Simonsson O, Chaturvedi S, Hendricks PS +5

Europe PMC2025
ArticlePsychedelics

Adolescent Psychedelic Use and Psychotic or Manic Symptoms.

Simonsson O, Mosing MA, Osika W +4

Europe PMC2024
ArticlePsychedelics

Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom.

Honk L, Stenfors CUD, Goldberg SB +6

Europe PMC2024
ArticlePsilocybin

Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.

Simonsson O, Hendricks PS, Stenfors CU +3

Europe PMC2024
ArticlePsychedelics

Psychedelic use and psychiatric risks.

Simonsson O, Goldberg SB, Chambers R +3

Europe PMC2025
ArticlePsilocybin

Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.

Simonsson O, Osika W, Stenfors CUD +3

Europe PMC2024
ArticlePsychedelics

Alternative beliefs in psychedelic drug users.

Lebedev AV, Acar K, Horntvedt O +5

Europe PMC2023
ArticlePsilocybin

Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.

Simonsson O, Stenfors CUD, Goldberg SB +2

Europe PMC2023
ArticlePsilocybin

Classic psychedelic use and current meditation practice.

Simonsson C, Chambers R, Hendricks PS +6

Europe PMC2023
ArticlePsilocybin

Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.

Simonsson O, Hendricks PS, Chambers R +2

Europe PMC2023
ArticlePsilocybin

Classic psychedelics, health behavior, and physical health.

Simonsson O, Hendricks PS, Chambers R +2

Europe PMC2022
ArticlePsilocybin

Prevalence and associations of classic psychedelic-related seizures in a population-based sample.

Simonsson O, Goldberg SB, Chambers R +3

Europe PMC2022
ArticlePsilocybin

Classic Psychedelics and Human-Animal Relations.

Pöllänen E, Osika W, Stenfors CUD +1

Europe PMC2022
ArticlePsychedelics

Associations between lifetime classic psychedelic use and cardiometabolic diseases.

Simonsson O, Osika W, Carhart-Harris R +1

Europe PMC2021